Assessment of inflammatory myositis

Current Opinion in Rheumatology

Volumn 13, Issue 6, 2001, Pages 488-492

  Dayal, Nimesh A ^a   Isenberg, David A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; CREATINE KINASE BLOOD LEVEL; DISEASE ACTIVITY; ELECTROMYOGRAM; HUMAN; INFLAMMATORY DISEASE; MEDICAL RESEARCH; MUSCLE STRENGTH; MYOSITIS; PRIORITY JOURNAL; REVIEW; TARGET ORGAN;

BLOOD; ELECTROMYOGRAPHY; HEALTH STATUS; HUMANS; MUSCLE, SKELETAL; MYOSITIS; SEROLOGIC TESTS;

EID: 0035169582     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200111000-00006     Document Type: Review

References (38)

1. Criteria for assessing disease activity in systemic lupus erythematosus
2. Caron D, Chang CH, and the committee on Prognosis Studies in SLE: Derivation of SLEDAI: A disease activity in systemic lupus erythematosus
3. The development of and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
4. Assessment of disease activity and its sequelae in children and adults with myositis
5. Muscle strength development and assessment in children and adolescents
6. Inter-and Intraobserver valuation in the interpretation of electromyographic tests
7. Reduced activity of serum creatine kinase in rheumatoid arthritis: A phenomenon linked to the inflammatory response
8. Clinical, biochemical and histologic responses to treatment in polymyositis: A prospective study
9. Serum enzyme, myoglobin and muscle strength relation in polymyositis and dermatomyositis
10. Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases
11. Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis
12. Von Willebrand factor in juvenile dermatomyositis
13. Elevated serum levels of neoptrin in adult patients with polymyositis/dermatomyositis
14. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis
15. Idiopathic inflammatory muscle disease: Clinical aspects
16. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis
17. Update on genetics of the idiopathic inflammatory myopathies
18. The idiopathic inflammatory myopathies: Spectrum of MR imaging findings
19. Magnetic resonance imaging in the idiopathic inflammatory myopathies
20. MR imaging in children with dermatomyositis: Musculoskeletal findings and correlation with clinical and laboratory findings
21. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis
22. Quantitative assessment of myositis in thigh muscle using magnetic resonance imaging
23. MRI directed muscle biopsy for assessment of juvenile dermatomyositis response to therapy: Comparison on initial and follow up biopsies using histologic rating scale evaluating disease severity/chronicity
24. Diagnosis of inflammatory myopathy: Usefulness of 99mTC-MDP scintigraphy and muscle MRI for determination of affected sites
25. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP
26. MRI-guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease
27. Percutaneous conchotome muscle biopsy: A useful diagnostic and assessment tool
28. Identifying skin lesions in dermatomyositis: Inter-rater reliability of a new cutaneous assessment tool
29. Sequential studies of nailfold capillaries vessels in 10 children with juvenile dermatomyositis: Correlation with disease activity score but not von Willebrand factor antigen
30. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis
31. Inflammatory muscle disease
32. Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients
33. Interstitial lung disease in polymyositis and dermatomyositis: Clinical features and prognosis as correlated with histologic findings
34. Measuring disability in juvenile dermatomyositis: Validity of the Childhood Health Assessment Scale
35. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis
36. Validation and rater reliability of the Childhood Myositis Assessment Scale
37. A functional index in myositis
38. Treatment of refractory myositis; a randomised crossover study of two new cytotoxic regimens